Literature DB >> 25523526

Evaluation of invalid vaccine doses in 31 countries of the WHO African Region.

Manas K Akmatov1, Elizabeth Kimani-Murage2, Frank Pessler3, Carlos A Guzman4, Gérard Krause5, Lothar Kreienbrock6, Rafael T Mikolajczyk5.   

Abstract

We examined (a) the fraction of and extent to which vaccinations were administered earlier than recommended (age-invalid) or with too short intervals between vaccine doses (interval-invalid) in countries of the World Health Organisation (WHO) African Region and (b) individual- and community-level factors associated with invalid vaccinations using multilevel techniques. Data from the Demographic and Health Surveys conducted in the last 10 years in 31 countries were used. Information about childhood vaccinations was based on vaccination records (n=134,442). Invalid vaccinations (diphtheria, tetanus, pertussis [DTP1, DTP3] and measles-containing vaccine (MCV)) were defined using the WHO criteria. The median percentages of invalid DTP1, DTP3 and MCV vaccinations across all countries were 12.1% (interquartile range, 9.4-15.2%), 5.7% (5.0-7.6%), and 15.5% (10.0-18.1%), respectively. Of the invalid DTP1 vaccinations, 7.4% and 5.5% were administered at child's age of less than one and two weeks, respectively. In 12 countries, the proportion of invalid DTP3 vaccinations administered with an interval of less than two weeks before the preceding dose varied between 30% and 50%. In 13 countries, the proportion of MCV doses administered at child's age of less than six months varied between 20% and 45%. Community-level variables explained part of the variation in invalid vaccinations. Invalid vaccinations are common in African countries. Timing of childhood vaccinations should be improved to ensure an optimal protection against vaccine-preventable infections and to avoid unnecessary wastage in these economically deprived countries.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Administration and dosage; Diphtheria–tetanus–pertussis vaccine; Measles-containing vaccine; Multilevel analysis; Timely vaccination; WHO African Region

Mesh:

Substances:

Year:  2014        PMID: 25523526     DOI: 10.1016/j.vaccine.2014.10.089

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Vaccination timeliness among newborns and infants in Ethiopia.

Authors:  Matthew L Boulton; Bradley F Carlson; Abram L Wagner; Julia M Porth; Berhanu Gebremeskel; Yemesrach Abeje
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

Review 2.  Characterization of immunization secondary analyses using demographic and health surveys (DHS) and multiple indicator cluster surveys (MICS), 2006-2018.

Authors:  Yue Huang; M Carolina Danovaro-Holliday
Journal:  BMC Public Health       Date:  2021-02-12       Impact factor: 3.295

3.  Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia.

Authors:  Teklay Desta; Ephrem Lemango; Daddi Wayessa; Liya Wondowossen; Mirkuzie Kerie; Balcha Masresha
Journal:  Pan Afr Med J       Date:  2021-12-16

4.  Timely immunization completion among children in Vietnam from 2000 to 2011: a multilevel analysis of individual and contextual factors.

Authors:  Dao Thi Minh An; Jong-Koo Lee; Hoang Van Minh; Nguyen Thi Huyen Trang; Nguyen Thi Thu Huong; You-Seon Nam; Do Van Dung
Journal:  Glob Health Action       Date:  2016-02-29       Impact factor: 2.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.